Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, ...

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.

But as a doctor I am very concerned that the mad scramble to get hold of semaglutide (brand names Ozempic and Wegovy) and tirzepatide (Mounjaro) has led to a Wild West market, where it's easy to ...

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

Novo may also have to price Wegovy more competitively in India after some industry watchers, such as market research firm Pharmarack, said Mounjaro's launch was "creating ripples" in the Asian ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy ... obesity drug Mounjaro in India ...